In today’s briefing:
- Accenture plc: Acquisition of MacGregor Partners & Other Drivers
- ECM Weekly (23rd Oct 2022) – Giant Biogene, Blibli, Bionote, Fusion Micro, Mitsubishi Estate
- Sirius XM Holding: Project Amplify Update & Key Drivers
- ZoomInfo Technologies Inc: ZoomInfo Labs Launch & Other Drivers
Accenture plc: Acquisition of MacGregor Partners & Other Drivers
- Accenture delivered a good performance in its last result surpassing Wall Street expectations in terms of revenues as well as earnings.
- The company’s revenues grew in local currency which was driven by double-digit growth across all industries, services, and markets.
- The cloud business of Accenture performed well, with Cloud First being one of the big drivers of growth.
ECM Weekly (23rd Oct 2022) – Giant Biogene, Blibli, Bionote, Fusion Micro, Mitsubishi Estate
- Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
- On the IPO front, Blibli launched its Indonesian IPO, while a few other names are said to be gearing up to launch in Hong Kong and India.
- There were a few placements this week, notable ones being Mitsubishi Estate Logistics (3481 JP) and Zee Entertainment Enterprises (Z IN).
Sirius XM Holding: Project Amplify Update & Key Drivers
- Sirius XM has had a volatile trajectory off late in terms of its stock price performance and with its results around the corner, another key factor that must be remembered is its history of below par earnings.
- The company is making progress in deploying its 360L platform, and it is making progress with various EV start-ups.
- We provide the stock of Sirius with a ‘Hold’ rating with a revision in the target price.
ZoomInfo Technologies Inc: ZoomInfo Labs Launch & Other Drivers
- With its next set of results around the corner, ZoomInfo Technologies definitely has a lot to look forward to.
- The company’s stock has remained stable in an otherwise bearish environment for the technology industry.
- We provide the stock of ZoomInfo with a ‘Buy’ rating with a revision in the target price.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
